Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
03 Sep 2013  |  Global  |  Technology Research
Innovations in Allergy Treatment and Monitoring (Technical Insights)
Therapy and Monitoring Advances Help Achieve Long-term Relief from Allergy
The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting informa...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Feb 2013  |  Global  |  Market Research
Overview of the Global Systemic Lupus Erythematosus Pipeline and the Next Three Potential Product Launches
This issue of Vital Signs discusses the change in 2015 Mammogram Guidelines, NeoGenomics' acquistion of Clarient from GE, and Tute Genomics' acquisition of Knome.
$1,500.00
Special Price $1,125.00 save 25 %
-
19 Jan 2012  |  Global  |  Technology Research
Advances in Pharmacovigilance Techniques--Technology Benchmarking and Stakeholder Analysis (Technical Insights)
A Drug Safety Toolkit Moving toward Improved Drug Safety Systems
Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies. Risks due...
$4,950.00
Special Price $3,712.50 save 25 %